Patent · US Active

Generation of functional and durable endothelial cells from human amniotic fluid-derived cells

US9637723B2 · kind B2 · utility

4Cited by

4References

12Claims

0Family size

Assignee

Cornell University · IT

Inventors

Shahin Rafii · Great Neck, US
Sina Y. Rabbany · Great Neck, US
Michael Ginsberg · Redmond, US

Key dates

Filing date	May 30, 2013
Grant date	May 2, 2017
Priority date	—
Expiry date	May 30, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2510/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure is directed to methods for reproducibly generating substantial amounts of endothelial cells from amniotic cells. The endothelial cells generated in accordance with the present methodology, as well as therapeutic methods utilizing these cells, are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.